Based on interview and record review, the facility failed to carry out critical medication level monitoring that was ordered and failed to consider whether the onset or worsening of symptoms, or a change of condition, may be related to the medication and failed to respond to the presence of adverse consequences related to the use of a high-risk medication for 1 of 3 sampled residents [Resident #1], which resulted in Resident #1's death. This citation is at the immediate jeopardy level due to the lack of an effective process to ensure medications are only administered with adequate monitoring of laboratory values, per manufacturers specifications and accepted professional standards for high risk medications, and not administered in the presence of adverse consequences which indicate the… …
F758 · Psychotropic drugs
Pharmacy Service Deficiencies
Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated, prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic medications are only used when the medication is necessary and PRN use is limited.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Every F758 citation surveyors wrote nationally that year.
Distinct nursing homes with at least one F758 finding.
The harm level
How severely F758 is cited
0.5% of citations found actual harm or worse (level G and above).
| Severity | Isolated | Pattern | Widespread |
|---|---|---|---|
| Immediate jeopardy | J30.1% | K10.0% | L10.0% |
| Actual harm | G190.4% | H10.0% | I— |
| No harm, potential for more than minimal | D4,14678.9% | E1,07020.4% | F70.1% |
| No harm, potential for minimal | A— | B40.1% | C— |
In the surveyor’s words
What an F758 citation says
One finding from each severity level, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
Based on interview and record review the facility failed to ensure residents entire drug/medication regimen was managed and monitored to promote or maintain their highest practicable mental, physical, and psychosocial well-being for 3 of 4 Residents (Residents 1, 2, & 38) who received psychotropic medications. Resident 1 experienced harm when the facility continued to administer antipsychotic medication without an approved clinical indication, evaluation of appropriateness, consideration for approved alternative treatments, monitoring, or evidence of non-pharmacological approaches that resulted in psychosocial and physical harm when they were transferred to the hospital due to altered mental status from the adverse effects of antipsychotic medication and was found to have an acute hip… …
Based on observation, interview, and record review, the facility failed to ensure 1 of 3 residents (Resident 4) were free of unnecessary psychotropic drugs (any drug that affects brain activities associated with mental processes and behavior). Failure for the facility to obtain informed consent for treatment with psychotropic drugs and to ensure Resident 4 was monitored for adverse side effects, placed residents at risk of not being fully informed of the risks and benefits of treatment with psychotropic drugs and to receive unnecessary psychotropic drugs. Findings included . Review of a facility assessment, dated 03/14/2025, showed Resident 4 had diagnoses which included Cellulitis (an infection of the skin and tissues beneath) of their lower legs, anxiety, and depression. …
Based on interview, medical record review, and facility P&P review, the facility failed to ensure one of two sampled residents (Resident 1) was provided the non-pharmacological interventions for the use of psychotropic medication (medication that affects the mind, emotions, and behavior). This failure had the potential to result in the unnecessary use of psychotropic medications for Resident 1. Findings: Review of the facility's P&P titled Antipsychotic Medication Use (undated) showed for enduring psychiatric conditions, antipsychotic medications will not be used unless behavioral symptoms are not sufficiently relieved by non-pharmacological interventions. …
By state — 2025
Where F758 is cited more, and less, than expected
Each state is measured against its own expected share, not against other states.
- Kansas2.58× · 27 citations
- Minnesota1.97× · 32 citations
- Iowa1.74× · 26 citations
- Washington1.55× · 28 citations
- California1.39× · 139 citations
- Illinois1.11× · 47 citations
- Michigan1.09× · 26 citations
- Pennsylvania1.03× · 43 citations
- Ohio0.64× · 26 citations
Co-occurrence
Cited alongside F758
Of the 2025 surveys that cited F758, these tags appeared in the same inspection more often than chance would predict.
- F62511.5% of F758 surveys · 9.7× chance
Notify the resident or the resident’s representative in writing how long the nursing home will hold the resident’s bed in cases of transfer to a hospital or therapeutic leave.
- F62312.6% of F758 surveys · 7.4× chance
Provide timely notification to the resident, and if applicable to the resident representative and ombudsman, before transfer or discharge, including appeal rights.
- F75622.5% of F758 surveys · 6.9× chance
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.
- F7008.3% of F758 surveys · 5.2× chance
Try different approaches before using a bed rail. If a bed rail is needed, the facility must (1) assess a resident for safety risk; (2) review these risks and benefits with the resident/representative; (3) get informed consent; and (4) Correctly install and maintain the bed rail.
- F8819.9% of F758 surveys · 5.0× chance
Implement a program that monitors antibiotic use.
Cited in the same inspection, not caused by one another.
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction